Prevest Denpro Ltd.
Snapshot View

408.00 +11.00 ▲2.8%

07 October 2022, 04:01:00 PM
Volume: 6,400

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.prevestdenpro.com
Market Cap 489.72 Cr.
Enterprise Value(EV) 448.75 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 9.64 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 42.33 Trailing Twelve Months Ending 2022-03
Industry PE 70.18 Trailing Twelve Months Ending 2022-03
Book Value / Share 50.64 Trailing Twelve Months Ending 2022-03
Price to Book Value 8.06 Calculated using Price: 408.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.20 Cr. 12,003,000 Shares
FaceValue 10
Company Profile
The company manufactures and markets a range of dental materials for diagnosing, treating, and preventing dental conditions and improving the aesthetics of the human smile.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.77%
1 Week
+3.99%
1 Month
-5.96%
3 Month
+35.26%
6 Month
-0.49%
1 Year
+78.13%
2 Year
5 Year
10 Year
5 years 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 29.72 34.02 39.13 38.13 29.07
Return on Capital Employed (%) 37.15 39.27 45.63 46.96 39.64
Return on Assets (%) 18.88 22.30 27.50 27.85 24.40

Balance Sheet View Details >>

Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 7 10 15 23 57
Non Curr. Liab. 1 2 2 2 2
Curr. Liab. 3 3 4 7 5
Minority Int.
Equity & Liab. 12 15 21 31 64
Non Curr. Assets 4 5 6 7 11
Curr. Assets 7 10 16 24 53
Misc. Exp. not W/O
Total Assets 12 15 21 31 64

Profit Loss View Details >>

Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 17 19 23 28 38
Other Income 1 0 2 1 2
Total Income 18 20 25 30 40
Total Expenditure -14 -15 -18 -19 -23
PBIDT 4 4 7 10 17
Interest 0 0 0 0 0
Depreciation 0 0 0 0 -1
Taxation -1 -1 -1 -2 -4
Exceptional Items
PAT 2 3 5 7 12
Adjusted EPS 76 105 176 8 10

Cash Flow View Details >>

Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 2 3 5 9 7
Cash Fr. Inv. -1 -1 -1 -2 -4
Cash Fr. Finan. 0 0 0 -1 23
Net Change 1 2 4 6 26
Cash & Cash Eqvt 4 6 10 16 42

Shareholding Pattern View Details >>

3 Qtrs 2021-09 (%) 2022-03 (%) 2022-06 (%)
Promoter 73.60 73.60 73.60
Public 26.40 26.40 26.40
Depository Receipts 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00

Announcements View Details >>

Fri, 30 Sep 2022
Closure of Trading Window
Pursuant to the Companys Code of Conduct for prevention of Insider Trading the Trading Window for dealing in the Companys Equity Shares will remain closed from Saturday October 1 2022 for all Designated Employees of the Company. The closure is in connection with the declaration of Unaudited Financial Results of the Company for the quarter ending on September 30 2022. The Trading Window will open 48 hours after the said financial results are declared to the Stock Exchanges.
Tue, 20 Sep 2022
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)
Prevest Denpro Ltd has informed BSE regarding the details of Voting results of AGM under Regulation 44(3) of SEBI (LODR) Regulations 2015. Kindly Click here
Sun, 18 Sep 2022
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Pursuant to Regulation 44(3) of the SEBI Listing Regulations we enclose the voting results in respect of the business transacted at the 23rd AGM in the format prescribed along with the consolidated Scrutinizers Report on remote e-voting prior and during the AGM.

Technical Scans View Details >>

Fri, 07 Oct 2022
High Delivery Percentage High Delivery Percentage
High Decrease 1 Month High Decrease 1 Month
High Increase 3 Months High Increase 3 Months
High Increase 1 Year High Increase 1 Year
Close Crossing 20 EMA From Below Close Crossing 20 EMA From Below

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,656.62 953.00 -0.1%
Divi's Laboratories Ltd. 99,250.74 3,738.70 +0.0%
Cipla Ltd. 91,332.41 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. 72,821.94 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. 63,207.02 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. 53,000.56 1,566.00 -2.3%
Zydus Lifesciences Ltd. 42,689.71 421.75 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.79 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 31.96 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 36.70 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.35 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.55 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 66.17 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.66 421.75 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.56 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 4.25 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.60 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.64 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.29 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.54 421.75 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 421.75 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 421.75 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 421.75 -0.3%

FAQ's On Prevest Denpro Ltd.

What is Prevest Denpro share price?

Can I buy Prevest Denpro shares now?

What is the Market Cap of Prevest Denpro?

What are the key metrics to analyse Prevest Denpro?

What is the 52 Week High and Low of Prevest Denpro?

What is the trend of Prevest Denpro share price?